CEMPRA INC's ticker is CEMP and the CUSIP is 15130J109. A total of 140 filers reported holding CEMPRA INC in Q4 2015. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $4,495,000 | +7.6% | 144,400 | -3.7% | 0.22% | +9.0% |
| Q3 2015 | $4,176,000 | +122.5% | 150,000 | -7.8% | 0.20% | +109.4% |
| Q1 2014 | $1,877,000 | -58.6% | 162,692 | -55.6% | 0.10% | -53.8% |
| Q4 2013 | $4,536,000 | -30.9% | 366,121 | -35.9% | 0.21% | -35.4% |
| Q3 2013 | $6,562,000 | +16.2% | 571,121 | -20.8% | 0.32% | -3.6% |
| Q2 2013 | $5,646,000 | – | 721,121 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 2,193,060 | $68,270,000 | 11.77% |
| Abingworth LLP | 383,935 | $11,948,000 | 7.21% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $7,783,000 | 3.72% |
| Opaleye Management Inc. | 200,000 | $6,226,000 | 2.60% |
| Knoll Capital Management, LLC | 180,800 | $5,628,000 | 2.09% |
| Palo Alto Investors LP | 1,175,733 | $36,601,000 | 2.04% |
| BB BIOTECH AG | 1,991,900 | $62,008,000 | 1.75% |
| AlpInvest Partners B.V. | 31,400 | $977,000 | 1.62% |
| GENERAL AMERICAN INVESTORS CO INC | 494,409 | $15,391,000 | 1.41% |
| HARVEY CAPITAL MANAGEMENT INC | 112,250 | $3,494,000 | 1.38% |